Position in BMY
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$329,183
-$23,375 QoQ
Shares Held
5,713
-1.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,818
of 2,514 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital Investment Counsel, Inc holds $4,343,317 across 8 Drug Manufacturers - General names. BMY ranks #5 (7.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
984 | $1,180,239 | |
| 2 | JNJ |
Johnson & Johnson
|
3,798 | $964,578 | |
| 3 | AMGN |
Amgen Inc
|
1,994 | $722,067 | |
| 4 | ABBV |
AbbVie Inc.
|
1,610 | $405,140 | |
| 5 | BMY |
Bristol Myers Squibb Co
This page
|
5,713 | $329,183 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,050 | $258,997 | |
| 7 | PFE |
Pfizer Inc
|
10,372 | $249,757 | |
| 8 | MRK |
Merck & Co., Inc.
|
1,816 | $233,356 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $329,183 | 5,713 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $352,558 | 5,813 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $265,330 | 4,919 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $257,926 | 5,719 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $258,714 | 5,589 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $312,512 | 5,124 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $289,813 | 5,124 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $273,135 | 5,279 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $216,952 | 5,224 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $279,609 | 5,156 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $269,736 | 5,257 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $325,430 | 5,607 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $358,567 | 5,607 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $381,620 | 5,506 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $396,156 | 5,506 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $302,132 | 4,250 | Shares | Sole | 2022-10-26 | |
| 2022-06-30 | $462,462 | 6,006 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $562,769 | 7,706 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $489,821 | 7,856 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $488,507 | 8,256 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $601,780 | 9,006 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $568,548 | 9,006 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $412,499 | 6,650 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $542,971 | 9,006 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $391,020 | 6,650 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $501,994 | 9,006 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||